Quarterly report · Q3
4885.TEDINET S100T9HF
Period2023-06-01 → 2024-02-29
Filed2024-04-12
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 38
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.5bn | 2023-06-01 → 2024-02-29 | Standalone | Net sales |
| Revenue | ¥6.3bn | 2022-06-01 → 2023-05-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥4.6bn | 2022-06-01 → 2023-02-28 | Standalone | Net sales |
| Operating income | ¥252m | 2023-06-01 → 2024-02-29 | Standalone | Operating income |
| Operating income | ¥325m | 2022-06-01 → 2023-02-28 | Standalone | Operating income |
| Ordinary income | ¥246m | 2023-06-01 → 2024-02-29 | Standalone | Ordinary income |
| Ordinary income | ¥351m | 2022-06-01 → 2023-05-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥309m | 2022-06-01 → 2023-02-28 | Standalone | Ordinary income |
| Profit before tax | ¥287m | 2023-06-01 → 2024-02-29 | Standalone | Income before income taxes |
| Profit before tax | ¥309m | 2022-06-01 → 2023-02-28 | Standalone | Income before income taxes |
| Net income | ¥191m | 2023-06-01 → 2024-02-29 | Standalone | Profit loss |
| Net income | ¥256m | 2022-06-01 → 2023-05-31 | Standalone | Net income loss (5-year summary) |
| Net income | ¥230m | 2022-06-01 → 2023-02-28 | Standalone | Profit loss |
| Total assets | ¥5.3bn | at 2024-02-29 | Standalone | Assets |
| Total assets | ¥4.9bn | at 2023-05-31 | Standalone | Assets |
| Total assets | ¥5.0bn | at 2023-02-28 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.2bn | at 2024-02-29 | Standalone | Liabilities |
| Total liabilities | ¥3.0bn | at 2023-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.1bn | at 2024-02-29 | Standalone | Net assets |
| Net assets / equity | ¥1.9bn | at 2023-05-31 | Standalone | Net assets |
| Net assets / equity | ¥1.9bn | at 2023-02-28 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥954m | at 2024-02-29 | Standalone | Cash and deposits |
| Cash and deposits | ¥853m | at 2023-05-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥48.2 | 2023-06-01 → 2024-02-29 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥24.52 | 2023-12-01 → 2024-02-29d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥67.94 | 2022-06-01 → 2023-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥61.46 | 2022-06-01 → 2023-02-28 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.53 | 2022-12-01 → 2023-02-28d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥47.27 | 2023-06-01 → 2024-02-29 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥64.12 | 2022-06-01 → 2023-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥58.55 | 2022-06-01 → 2023-02-28 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥19 | 2022-06-01 → 2023-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Equity ratio | 39.9% | at 2024-02-29 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.7% | at 2023-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.5% | at 2023-02-28 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 4,095,500 | at 2024-02-29 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2023-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2023-02-28 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥1.6bn |
| jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥1.6bn |
| jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segment | segment profit | 2023-06-01 → 2024-02-29 | −¥22m |
| jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥563m |
| jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥563m |
| jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segment | segment profit | 2023-06-01 → 2024-02-29 | −¥40m |
| jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥2.3bn |
| jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥2.3bn |
| jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segment | segment profit | 2023-06-01 → 2024-02-29 | ¥314m |
| —segment total | revenue | 2023-06-01 → 2024-02-29 | ¥4.5bn |
| —segment total | revenue external | 2023-06-01 → 2024-02-29 | ¥4.5bn |
| —segment total | segment profit | 2023-06-01 → 2024-02-29 | ¥252m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-06-01 → 2024-02-29 | ¥4.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-06-01 → 2024-02-29 | ¥4.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-06-01 → 2024-02-29 | ¥252m |
| jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥1.5bn |
| jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥1.5bn |
| jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segment | segment profit | 2022-06-01 → 2023-02-28 | −¥25m |
| jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥528m |
| jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥528m |
| jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segment | segment profit | 2022-06-01 → 2023-02-28 | −¥75m |
| jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥2.6bn |
| jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥2.6bn |
| jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥426m |
| —segment total | revenue | 2022-06-01 → 2023-02-28 | ¥4.6bn |
| —segment total | revenue external | 2022-06-01 → 2023-02-28 | ¥4.6bn |
| —segment total | segment profit | 2022-06-01 → 2023-02-28 | ¥325m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2023-02-28 | ¥4.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2023-02-28 | ¥4.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2023-02-28 | ¥325m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 369
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating income | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000PharmaceuticalBusinessReportableSegmentMember | 425507000 | JPY |
| Operating income | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000HealthyFoodBusinessReportableSegmentMember | -74757000 | JPY |
| Operating income | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000ChemicalProductsBusinessReportableSegmentMember | -25340000 | JPY |
| Operating income | Prior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember | 325409000 | JPY |
| Operating income | Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | 325409000 | JPY |
| Operating income | Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember | - | JPY |
| Operating income | Prior1YTDDuration_NonConsolidatedMember | 325409000 | JPY |
| Revenues from external customers | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000PharmaceuticalBusinessReportableSegmentMember | 2250660000 | JPY |
| Revenues from external customers | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000HealthyFoodBusinessReportableSegmentMember | 562884000 | JPY |
| Revenues from external customers | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000ChemicalProductsBusinessReportableSegmentMember | 1641467000 | JPY |
| Revenues from external customers | CurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember | 4455013000 | JPY |
| Revenues from external customers | CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | 4455013000 | JPY |
| Revenues from external customers | CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember | - | JPY |
| Revenues from external customers | CurrentYTDDuration_NonConsolidatedMember | 4455013000 | JPY |
| Transactions with other segments | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000PharmaceuticalBusinessReportableSegmentMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000HealthyFoodBusinessReportableSegmentMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000ChemicalProductsBusinessReportableSegmentMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_NonConsolidatedMember | - | JPY |
| Net sales | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000PharmaceuticalBusinessReportableSegmentMember | 2250660000 | JPY |
| Net sales | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000HealthyFoodBusinessReportableSegmentMember | 562884000 | JPY |
| Net sales | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000ChemicalProductsBusinessReportableSegmentMember | 1641467000 | JPY |
| Net sales | CurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember | 4455013000 | JPY |
| Net sales | CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | 4455013000 | JPY |
| Net sales | CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember | - | JPY |
| Net sales | CurrentYTDDuration_NonConsolidatedMember | 4455013000 | JPY |
| Operating income | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000PharmaceuticalBusinessReportableSegmentMember | 313619000 | JPY |
| Operating income | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000HealthyFoodBusinessReportableSegmentMember | -39613000 | JPY |
| Operating income | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000ChemicalProductsBusinessReportableSegmentMember | -21617000 | JPY |
| Operating income | CurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember | 252388000 | JPY |
| Operating income | CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | 252388000 | JPY |
| Operating income | CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember | - | JPY |
| Operating income | CurrentYTDDuration_NonConsolidatedMember | 252388000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の4の7第1項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)福岡財務支局長 | |
| Filing date cover page | FilingDateInstant | 2024-04-12 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第78期第3四半期(自 2023年12月1日 至 2024年2月29日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)室町ケミカル株式会社 | |
| Company name in english cover page | FilingDateInstant | MUROMACHI CHEMICALS INC. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 青木 淳一 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)福岡県大牟田市新勝立町一丁目38番5 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 0944-41-2131 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役 管理本部長 井内 聡 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)福岡県大牟田市新勝立町一丁目38番5 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 0944-41-2131 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役 管理本部長 井内 聡 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |